Advancement in the research of growth hormone in treating pediatric burn patients.
- Author:
Fei WANG
1
;
Lin QIU
Author Information
1. Department of Burns and Plastic Surgery, the Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
- Publication Type:Journal Article
- MeSH:
Burns;
drug therapy;
Child;
Human Growth Hormone;
therapeutic use;
Humans;
Recombinant Proteins;
therapeutic use
- From:
Chinese Journal of Burns
2013;29(1):18-21
- CountryChina
- Language:Chinese
-
Abstract:
The serious and persistent hypercatabolic state caused by severe burn injury leads to weight loss, weakening of muscles, immunity decline, and delayed wound healing in injured patients. Pediatric burn patients also suffer growth retardation. How to ameliorate the persistent hypercatabolic response is what the medical professionals should concern. Recombinant human growth hormone (rhGH) can attenuate the hypercatabolic response and alleviate the growth retardation. This article reviews the researches on the use of rhGH in the treatment of burn injury in children.
